Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
Key Points
Key points are not available for this paper at this time.
Abstract
NIHR Health Technology Assessment programme.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial | Synapse